Navigation Links
Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule
Date:3/19/2012

GREENWOOD VILLAGE, Colo., March 19, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Zertane™ completed two phase III studies, Ampion™-completed proof of concept studies and Optina™), licensing distribution of these drugs and engaged in further drug development, today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina™ trial for diabetic macular edema.

Conducted at St. Michael Hospital in Toronto Canada, the trial explored the safety and efficacy of twice-daily oral doses of Optina™, to reduce macular edema as determined by OCT (optical coherence tomography). OCT is a measure of the thickness of the macula, the area of the retina responsible for color and sharp vision. Macular edema, or swelling of that part of the retina, is a common consequence of diabetes and is the first step in the development of diabetic blindness.

According to Dr. Vaughan Clift, Chief Regulatory Officer of Ampio, "A preliminary assessment, of the primary end point (OCT) indicates a beneficial and consistent effect with the ultra-low dose of Optina™ at 4 and 12 weeks of treatment and no apparent benefit at the high dose. These preliminary results are in keeping with the in-vitro data, which demonstrated a biphasic effect of the drug (effective in reducing vascular permeability at very low doses and cessation of these beneficial effects at the higher doses, which are used clinically for other approved indications)."

Dr. Clift continued, "Based on these positive and encouraging results and the potential of lack of efficacy at the higher doses, both doses being present in this study, Ampio decided to conclude this study ahead of schedule and to proceed with the preparation of a consultation pack
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
2. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
3. Atlanta-based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Failure Monitoring
4. U.S. Patent Issued for Champions Biotechnologys Lead Oncology Drug
5. Champions Biotechnology, Inc. Signs Exclusive Licensing Agreement with Ramot for TAR-1, a Novel Therapeutic for the Treatment of Cancer
6. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results
7. Chay Enterprises Inc. Completes Merger With Repurposed Drug Developer Ampio Pharmaceuticals, Inc.
8. Ampio Pharmaceuticals, Inc. Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning
9. Ampio Pharmaceuticals to Acquire DMI Biosciences, Inc.
10. Ampio Pharmaceuticals, Inc. Appoints New Chairman and Chief Financial Officer
11. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)...  Lakeland Industries, Inc. (NASDAQ: LAKE ... clothing for industry, municipalities, healthcare and first responders ... announced that the Company accepted a commitment letter ... subject to certain terms and conditions and is ... assurances can be given that this transaction or ...
(Date:5/21/2013)... 21 de mayo de 2013 La junta ... filiales incluyen OMNIlife science®, Inc., Enztec, Ltd. y Praxim, ... su junta. Guy Mayer, un ejecutivo ortopédico experimentado, será ... David Johnson , un experto refutado en ... Antes de unirse a OSI como presidente de ...
(Date:5/21/2013)... CINCINNATI , May 21, 2013  LCA-Vision Inc. (NASDAQ: ... correction services under the Lasik Plus ® brand, announces that ... to one-year terms at today,s annual meeting of stockholders.  These ... , co-founder and President of Bahl & Gaynor Investment Counsel ... with BSC Ventures , Edgar F. Heizer ...
Breaking Medicine Technology:Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 3Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 4Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 5Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 6Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 7Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 8Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 9Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 10Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 11Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 12Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 13Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 3LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4
... 4Q07/1Q08, DALLAS, Aug. 20 Access Pharmaceuticals, ... on the clinical,development plan of ProLindac, its novel ... human clinical trials to be initiated in,late 2007/ ... ovarian,cancer patients, designed to optimize single agent dosing ...
... in the journal Blood found 92 percent reduction in ... ... Patients with a rare,blood disorder called PNH experienced a ... following treatment,with Soliris(TM) (eculizumab), according to an analysis of clinical ...
Cached Medicine Technology:Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 2Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 3Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 2PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 3PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 5PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 6PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 7PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 8
(Date:5/22/2013)... Asthma, a disorder that causes the airways ... shortness of breath, chest tightness and coughing without sputum ... the airways become tight and the lining of the ... can pass. Asthma attacks can last for minutes to ... Reuters reports that there is a link ...
(Date:5/22/2013)... 22, 2013 Poor adherence to appropriate ... only medical complications and death (some 125,000 deaths in ... but increased health-care costs. It’s been estimated that between ... related to poor medication adherence — a reality that ... , Indeed, so dire is the degree of medication ...
(Date:5/22/2013)... Those who have already gone through a ... the hardest work is yet to come. As of April ... patients have special health needs that should be addressed in ... Lap-Band Surgery” abclocal.go.com/kabc/story?section=news/food_coach&id=9078455). Bariatric surgeon Dr. Madan offers four tips ... weight can be lost and kept off. , First, ...
(Date:5/22/2013)... SAN DIEGO, CA (PRWEB) May 22, 2013 ... active lifestyle media and publishing company released today ... The 10 healthiest business hotels received the company’s ... traveler feedback, and anonymous personal tours by the ... multi-sport options (e.g., lap pool, sport court, etc.), ...
(Date:5/21/2013)... The University of Colorado’s Anschutz Health and ... to help Coloradans make healthier choices when they eat ... called HEALTHY DINING IN COLORADO. More than 40 ... Colorado. Restaurants will offer a selection of dietitian verified ... vegetables, fruits, whole grains and unsaturated fats. , “Families ...
Breaking Medicine News(10 mins):Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2Health News:The Lap Band Center: Dr. Atul Madan Offers Five Tips for Ongoing Weight Loss for Lap Band Patients 2Health News:The Lap Band Center: Dr. Atul Madan Offers Five Tips for Ongoing Weight Loss for Lap Band Patients 3Health News:2013: The 10 Healthiest Business Hotels in the U.S. 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 3
... could offer clues to effects of aging, experts say ... that plays an important role in coordinating people,s circadian ... , The circadian clock governs daily cycles of ... University and the Washington University School of Medicine said ...
... ,Celebrating case reports, the stories in health care, will be ... 15 May this year, and will bring together leading doctors ... the Editors of Cases Network,s journals Richard Smith (the ... University, Australia). , Richard Smith said of Cases Network,s goal, ...
... Annual American Academy of Dermatology MeetingCRANFORD, N.J., March 19 ... Lipocream(R) (hydrocortisone butyrate 0.1%) the leading mid-potency corticosteroid ... recently launched Locoid(R) Lotion . ... Dermatology (AAD) meeting in San Francisco, ...
... The "Help is Here Express" bus tour will be ... various cities throughout the state in order to help ... provide prescription medicines for free or nearly free. With ... months, and having passed the national unemployment rate (7.6 ...
... Pa., March 19 eHealth specialist InterComponentWare (ICW) has ... at the IHE North American Connectathon, the only large-scale ... the past three years the interoperability of ICW,s Master ... conformant. The interoperability of the ICW MPI succeeded ...
... 19 VNUS Medical Technologies, Inc. (Nasdaq: VNUS ... invasive treatment of venous reflux disease, today announced its plans ... Growth Institutional Investor Forum, to be held March 24 - ... City. The management speaker will be Peter Osborne, Chief ...
Cached Medicine News:Health News:Internal Clock and Metabolism May Be Linked 2Health News:Triax Pharmaceuticals, Providers of the No. 1 Prescribed Mid-Potency Corticosteroid Brand, Introduce a New Size of Locoid Lotion 0.1% 2Health News:Partnership for Prescription Assistance Prepared to Help Georgia Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help Georgia Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help Georgia Workers Hurt by Recession 4Health News:ICW Master Patient Index Passes HITSP Certification and IHE Tests 2
... order products are offered as 1-piece or ... The modular instruments may be customized with ... as ratchets, insulation and flush ports. Many ... Customer specifications may affect delivery times. ...
... offered as 1-piece or modular, in regular ... may be customized with handles of choice ... and flush ports. Many standard patterns are ... affect delivery times. , Please Note: ...
... products are offered as 1-piece or modular, ... modular instruments may be customized with handles ... ratchets, insulation and flush ports. Many standard ... specifications may affect delivery times. , ...
... Featured Products are kept ... and are offered as ... regular or extra long ... with insulation, flush ports, ...
Medicine Products: